about
Beta₂-agonists for exercise-induced asthmaBeta-2 agonists for exercise induced asthmaTreatment of exercise-induced asthma, respiratory and allergic disorders in sports and the relationship to doping: Part II of the report from the Joint Task Force of European Respiratory Society (ERS) and European Academy of Allergy and Clinical ImmAsthma outcomes: pulmonary physiology.Approach to the diagnosis and management of suspected exercise-induced bronchoconstriction by primary care physiciansExercise-Induced Asthma Symptoms and Nighttime Asthma: Are They Similar to AHR?Cromoglycate, reproterol, or both--what's best for exercise-induced asthma?Special considerations for adolescent athletic and asthmatic patients.Exercise and asthma: an overview.An evaluation of levalbuterol HFA in the prevention of exercise-induced bronchospasm.A standard, single dose of inhaled terbutaline attenuates hyperpnea-induced bronchoconstriction and mast cell activation in athletesExercise-induced bronchoconstriction: new evidence in pathogenesis, diagnosis and treatment.Mechanisms of asthma in Olympic athletes--practical implications.Loss of salmeterol bronchoprotection against exercise in relation to ADRB2 Arg16Gly polymorphism and exhaled nitric oxideTreatment options for the management of exercise-induced asthma and bronchoconstriction.Asthma in elite athletes: pathogenesis, diagnosis, differential diagnoses, and treatment.Warm-up exercise can reduce exercise-induced bronchoconstriction.Pediatric exercise-induced bronchoconstriction: contemporary developments in epidemiology, pathogenesis, presentation, diagnosis, and therapy.Exercise-Induced Bronchospasm and Allergy.Pharmacotherapy for exercise-induced asthma: allowing normal levels of activity and sport.Beta2-agonists for exercise-induced asthma.Airway hyperresponsiveness in asthma: mechanisms, clinical significance, and treatment.Effect of fish oil-derived omega-3 polyunsaturated Fatty Acid supplementation on exercise-induced bronchoconstriction and immune function in athletes.Protective effect of a low single dose inhaled steroid against exercise induced bronchoconstriction.A prebiotic galactooligosaccharide mixture reduces severity of hyperpnoea-induced bronchoconstriction and markers of airway inflammation.Sodium cromoglycate and eformoterol attenuate sensitivity and reactivity to inhaled mannitol in subjects with bronchiectasis.Practical approach to exercise-induced bronchoconstriction in athletes.Not all wheeze is asthma: time for patients to exercise their rights.
P2860
Q24197597-BD554A77-C590-4F77-850B-CA938E681145Q24240704-D70C141A-C38E-4A30-8472-AA7F0CC80349Q28275393-100587D3-55DF-4747-BDCD-6CBECC975C39Q30423167-FC5E6BFA-9FD0-4A5A-921C-29CC24886F54Q33467580-C9BAFB84-BA3F-4DE9-8561-32441B6CC065Q34217787-D57A1BE7-82C3-453B-B189-B2FF96ECA928Q34242972-84835ED6-9DAD-4B5A-8E1E-7A3013588C2EQ34394995-AE589B53-9063-4D2E-B9B7-45F260C969EBQ36300614-0F1AB26C-29ED-4A9C-B48C-35AC68195283Q36693149-EC28DF2F-8E8E-4C26-8D05-F0D40226FC0DQ36973812-B24CB60C-1C87-4D07-94D4-AF3DEA57B0BAQ37145976-B6FA3935-5580-4CF4-AB62-D0ED2C40891EQ37150469-B7D237FE-E998-47C5-BE25-31B36BD74EB6Q37566530-E715550F-6FF3-472E-A03C-C60EE0E85BFEQ37819748-C84A9952-5972-445E-BD79-AB0FABC06D0AQ37949858-2391C718-206F-4FB9-9F70-BE5EFC9B2F20Q38049582-76F32948-5D21-4A2A-B6B5-844D4930EB09Q38127399-07E784D5-805D-4CE0-AD75-A297787B5043Q38712916-CDEC41A4-5592-4BF2-9F53-CDB31A390292Q39914397-511A7983-AA78-4774-BC39-1EE5CCC6BEACQ41957657-F979FCE3-0201-4234-A134-2A4C7BEA2B08Q42401081-E37C9EDC-5D11-4C5D-96F8-6B123B56D910Q43202599-5CAE2BD2-63B3-4D2D-95F3-D72401167938Q46337949-768B505A-A96D-4D8A-AABF-3208DA424AD7Q48113306-FB3AA846-B06C-4FBD-9877-D138D94DF1D2Q48333448-2D384E6C-2D8C-4C70-8F03-8ADCCAEE8FD1Q51251799-D73ABB74-981F-4BB3-8856-8B2B3BA48E05Q51683924-CDFBDC6B-C7AA-4E3D-B044-446EC9E460B4
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Beta2-agonists and exercise-induced asthma.
@ast
Beta2-agonists and exercise-induced asthma.
@en
type
label
Beta2-agonists and exercise-induced asthma.
@ast
Beta2-agonists and exercise-induced asthma.
@en
prefLabel
Beta2-agonists and exercise-induced asthma.
@ast
Beta2-agonists and exercise-induced asthma.
@en
P356
P1476
Beta2-agonists and exercise-induced asthma.
@en
P2093
Corinne Caillaud
John D Brannan
P2888
P304
P356
10.1385/CRIAI:31:2:163
P577
2006-10-01T00:00:00Z
P6179
1000176983